Literature DB >> 1563520

Formation of free sphingosine and ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture.

L Riboni1, R Bassi, S Sonnino, G Tettamanti.   

Abstract

Cerebellar granule cells differentiated in culture were incubated with ganglioside [3H-Sph]GM1 in order to have it inserted into the plasma membrane and metabolized. Among the formed metabolites radioactive sphingosine and ceramide were identified. [3H]Ceramide started to be measurable after 10 min of incubation (pulse), and [3H]sphingosine after 15 min. Their concentrations increased with pulse time, and, after a 1-hour pulse, with chase time. After a 1-hour pulse with 2 x 10(-6) M [3H-Sph]GM1 followed by a 4-hour chase, the amount of [3H]sphingosine and [3H]ceramide formed were 0.04 and 0.4 pmol/10(6) cells, respectively. Particularly the ability to produce sphingosine was higher in differentiated than in undifferentiated cells. It is concluded that ganglioside turnover contributes to the maintenance of the intracellular levels of free sphingosine and ceramide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563520     DOI: 10.1016/0014-5793(92)80193-k

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture.

Authors:  L Riboni; R Bassi; A Prinetti; P Viani; G Tettamanti
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

2.  Sphingolipid metabolism and caveolin expression in gonadotropin-releasing hormone-expressing GN11 and gonadotropin-releasing hormone-secreting GT1-7 neuronal cells.

Authors:  Simona Prioni; Nicoletta Loberto; Alessandro Prinetti; Vanna Chigorno; Francesca Guzzi; Roberto Maggi; Marco Parenti; Sandro Sonnino
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

3.  Metabolic formation of ceramide-1-phosphate in cerebellar granule cells: evidence for the phosphorylation of ceramide by different metabolic pathways.

Authors:  Laura Riboni; Rosaria Bassi; Viviana Anelli; Paola Viani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  Efflux of sphingolipids metabolically labeled with [1-3H]sphingosine, L-[3- 3H]serine and [9,10- 3H]palmitic acid from normal cells in culture.

Authors:  Vanna Chigorno; Mariateresa Sciannamblo; Joanna Mikulak; Alessandro Prinetti; Sandro Sonnino
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

5.  Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1.

Authors:  F Wang; N E Buckley; A Olivera; K A Goodemote; Y Su; S Spiegel
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

6.  Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice.

Authors:  Federica Scandroglio; Jagadish Kummetha Venkata; Nicoletta Loberto; Simona Prioni; Edward H Schuchman; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

7.  Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides.

Authors:  C Dumontet; A Rebbaa; J Bienvenu; J Portoukalian
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

8.  Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis.

Authors:  Alessandro Prinetti; Federica Rocchetta; Elvira Costantino; Annalisa Frattini; Elena Caldana; Francesca Rucci; Arianna Bettiga; Pietro L Poliani; Vanna Chigorno; Sandro Sonnino
Journal:  Glycoconj J       Date:  2008-09-10       Impact factor: 2.916

9.  Cultured cerebellar granule cells, but not astrocytes, produce an ester of ganglioside GD1b, presumably GD1b monolactone, from exogenous GD1b.

Authors:  R Bassi; L Riboni; G Tettamanti
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

10.  ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study.

Authors:  Massimiliano Filosto; Massimo Aureli; Barbara Castellotti; Fabrizio Rinaldi; Domitilla Schiumarini; Manuela Valsecchi; Susanna Lualdi; Raffaella Mazzotti; Viviana Pensato; Silvia Rota; Cinzia Gellera; Mirella Filocamo; Alessandro Padovani
Journal:  Eur J Hum Genet       Date:  2016-03-30       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.